SOUTHFIELD, Mich., – Nathan Reed, Ph.D. and associate in Brooks Kushman`s Southfield office, was quoted in the Michigan Lawyers Weekly article “U.S. Supreme Court Splits Gene Patents Issue,” which ran in the June 24 issue of the publication.
In the article discussing the June 13th U.S. Supreme Court decision about the patentability of isolated human genes versus synthetically created genetic material, Reed commented that the decision essentially “split the baby,” denying patentability for the gene itself, but allowing cDNA (“a synthetically created composite genetic material”) patentable. He goes onto discuss possible strategies for life science companies to protect their investments, noting that there`s still an economic incentive for those in the industry.
For more information about the article, please visit Michigan Lawyers Weekly or for additional insight on the decision, please contact Nathan Reed.
About Brooks Kushman:
Established in 1983, Brooks Kushman P.C. is a nationally ranked intellectual property (IP) and technology focused law firm with offices across the nation. The firm has more than 70 lawyers and agents specializing in various disciplines. Brooks Kushman has a reputation for providing leading IP strategy and counseling with a focus on the business objectives of its clients and represents clients across many industries with respect to protection, enforcement and monetization of IP, including patents, trademarks, copyright and trade secrets.
Brooks Kushman counts a number of Fortune 100 companies across a variety of industries among its clients. The firm is recognized by a number of leading legal publications and resources, including Corporate Counsel magazine, U.S. News & World Report, IP Law & Business magazine and the Law360 organization. For more information, please visit brookskushman.com.